BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31523119)

  • 1. Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity.
    Call M; Elzarka M; Kunesh M; Hura N; Birk DE; Kao WW
    Mol Vis; 2019; 25():415-426. PubMed ID: 31523119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of human umbilical mesenchymal stem cells cures the corneal defects of mucopolysaccharidosis VII mice.
    Coulson-Thomas VJ; Caterson B; Kao WW
    Stem Cells; 2013 Oct; 31(10):2116-26. PubMed ID: 23897660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen V is a dominant regulator of collagen fibrillogenesis: dysfunctional regulation of structure and function in a corneal-stroma-specific Col5a1-null mouse model.
    Sun M; Chen S; Adams SM; Florer JB; Liu H; Kao WW; Wenstrup RJ; Birk DE
    J Cell Sci; 2011 Dec; 124(Pt 23):4096-105. PubMed ID: 22159420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly.
    Chen S; Young MF; Chakravarti S; Birk DE
    Matrix Biol; 2014 Apr; 35():103-11. PubMed ID: 24447998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decorin regulates collagen fibrillogenesis during corneal wound healing in mouse in vivo.
    Gupta S; Buyank F; Sinha NR; Grant DG; Sinha PR; Iozzo RV; Chaurasia SS; Mohan RR
    Exp Eye Res; 2022 Mar; 216():108933. PubMed ID: 35031282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice.
    Liu H; Zhang J; Liu CY; Wang IJ; Sieber M; Chang J; Jester JV; Kao WW
    PLoS One; 2010 May; 5(5):e10707. PubMed ID: 20502663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma.
    Chakravarti S; Petroll WM; Hassell JR; Jester JV; Lass JH; Paul J; Birk DE
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3365-73. PubMed ID: 11006226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of corneal fibrosis by imaging second harmonic-generated signals in rabbit corneas treated with mitomycin C after excimer laser surface ablation.
    Farid M; Morishige N; Lam L; Wahlert A; Steinert RF; Jester JV
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4377-83. PubMed ID: 18502995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of corneal transparency.
    Hassell JR; Birk DE
    Exp Eye Res; 2010 Sep; 91(3):326-35. PubMed ID: 20599432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural abnormalities of the cornea and lid resulting from collagen V mutations.
    Segev F; Héon E; Cole WG; Wenstrup RJ; Young F; Slomovic AR; Rootman DS; Whitaker-Menezes D; Chervoneva I; Birk DE
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):565-73. PubMed ID: 16431952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VI.
    Alroy J; Haskins M; Birk DE
    Exp Eye Res; 1999 May; 68(5):523-30. PubMed ID: 10328965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Feasibility of Intrastromal Injection of Cultivated Human Corneal Stromal Keratocytes as Cell-Based Therapy for Corneal Opacities.
    Yam GH; Fuest M; Yusoff NZBM; Goh TW; Bandeira F; Setiawan M; Seah XY; Lwin NC; Stanzel TP; Ong HS; Mehta JS
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3340-3354. PubMed ID: 30025076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered KSPG expression by keratocytes following corneal injury.
    Carlson EC; Wang IJ; Liu CY; Brannan P; Kao CW; Kao WW
    Mol Vis; 2003 Nov; 9():615-23. PubMed ID: 14654769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal and spatial analysis of stromal cell and extracellular matrix patterning following lamellar keratectomy.
    Kivanany PB; Grose KC; Petroll WM
    Exp Eye Res; 2016 Dec; 153():56-64. PubMed ID: 27732879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The corneal fibrosis response to epithelial-stromal injury.
    Torricelli AA; Santhanam A; Wu J; Singh V; Wilson SE
    Exp Eye Res; 2016 Jan; 142():110-8. PubMed ID: 26675407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal Fibroblast Migration Patterns During Intrastromal Wound Healing Correlate With ECM Structure and Alignment.
    Petroll WM; Kivanany PB; Hagenasr D; Graham EK
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7352-61. PubMed ID: 26562169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bone marrow and adipose tissue-derived mesenchymal stem cells on the natural course of corneal scarring after penetrating injury.
    Demirayak B; Yüksel N; Çelik OS; Subaşı C; Duruksu G; Unal ZS; Yıldız DK; Karaöz E
    Exp Eye Res; 2016 Oct; 151():227-35. PubMed ID: 27567556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of fibrillar collagen in the human and bovine cornea: collagen types V and III.
    White J; Werkmeister JA; Ramshaw JA; Birk DE
    Connect Tissue Res; 1997; 36(3):165-74. PubMed ID: 9512886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced regeneration of corneal tissue via a bioengineered collagen construct implanted by a nondisruptive surgical technique.
    Koulikovska M; Rafat M; Petrovski G; Veréb Z; Akhtar S; Fagerholm P; Lagali N
    Tissue Eng Part A; 2015 Mar; 21(5-6):1116-30. PubMed ID: 25412075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratocytes are induced to produce collagen type II: A new strategy for in vivo corneal matrix regeneration.
    Greene CA; Green CR; Dickinson ME; Johnson V; Sherwin T
    Exp Cell Res; 2016 Sep; 347(1):241-249. PubMed ID: 27539660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.